Search results

Filters

  • Journals
  • Authors
  • Keywords
  • Date
  • Type

Search results

Number of results: 4
items per page: 25 50 75
Sort by:
Download PDF Download RIS Download Bibtex

Abstract

We measured the bone-specific alkaline phosphatase (ALP) isoenzyme activity in 67 plasma samples from 14 newborn Holstein calves using both a conventional method (featuring heat inactivation) and a commercial agarose gel electrophoresis (AGE) kit; the relevant isoenzymes were termed bone-specific ALP (BAP) and ALP isoenzyme 3 (ALP3). We explored whether the AGE kit afforded reliable data when used to analyze samples from Holstein calves. The blood was collected from the jugular vein of each calf immediately prior to the first colostrum feeding (pre-feeding), 20 and 40 h after pre-feeding, and on days 4 and 7; whereas three samples (from three calves) were not obtained. The total plasma ALP activity varied widely, exceeding the ranges of reference values. On electrophoresis, 52 of 67 plasma samples (77.6 %) clearly contained both ALP isoenzyme 2 and ALP3, as did control human serum. The total ALP activity of the 52 samples ranged from 166–1989 U/L (median: 1013 U/L), whereas the values for the other 15 samples (22.4%) exhibiting abnormal isoenzyme fractionation ranged from 1014–5118 U/L (median: 1780 U/L). In the 52 plasma samples exhibiting clearly separated isoenzymes, ALP3 and BAP activities were strongly positively correlated as revealed by Deming regression (y = 0.93x + 22.6, p<0.0001) and Bland-Altman analysis (ALP3/BAP activities limit of agreement: −5.1%). Thus, the AGE kit yields useful information on newborn calves, and can replace the conventional method when the total plasma ALP activity is less than approximately 1000 U/L.

Go to article

Authors and Affiliations

R. Onomi
K. Hatate
N. Yamagishi
Download PDF Download RIS Download Bibtex

Abstract

A recent study found that an agarose gel electrophoresis (AGE) method yielded two distinct major bands corresponding to the hepatic and bone ALP isoenzymes (ALP2 and ALP3, respectively) in bovine serum treated with protease and neuraminidase (PN-treatment), although there were concerns that the intestinal ALP isoenzyme (ALP5) often overlapped with ALP3 in human serum treated with neuraminidase. Because ALP5 was separated from ALP3 in bovine serum treated with protease alone (P-treatment), we used a modified method employing both P- and PN-treated bovine sera to measure the activities of the three ALP isoenzymes in 53 lactating Holstein cows: 24 primiparous and 29 multiparous. Upon electrophoresis, 51 of 53 samples (96.2%) subjected to P-treatment yielded a distinct fraction corresponding to ALP5, as did the control serum. All PN-treated sera yielded a definite ALP2 fraction. The ALP3 fraction was calculated as the remainder after excluding ALP2 and ALP5. The activities of total ALP (t-ALP) and ALP3 in primiparous cows were higher than those in multiparous cows (p < 0.001) at early-to-peak [10–110 days in milk (DIM)] and mid (111–220 DIM) lactation. In the multiparous cows, the ALP3 activity at late lactation (221−477 DIM) was significantly higher than that at early-to-peak lactation. Thus, the modified AGE method described here is able to discriminate three fractions of ALP isoenzymes in the sera of lactating cows. The AGE pattern of circulating ALP isoenzymes will contribute to the understanding of the physiological bone metabolism status in lactating cows.

Go to article

Authors and Affiliations

A. Chiba
K. Hatate
R. Onomi
T. Moriyama
A. Goto
N. Yamagishi
Download PDF Download RIS Download Bibtex

Abstract

This study investigated changes in serum levels of hepatic, bone, and intestinal alkaline phosphatase (ALP) isoenzymes (ALP2, ALP3, and ALP5, respectively) in Holstein cows around parturition. Tartrate-resistant acid phosphatase 5b (TRAP5b) activity and calcium (Ca) concen- trations were also measured. We analyzed blood samples from 11 late-pregnant heifers (primipa- rous group) and 13 multiparous (2-4 lactations; multiparous group) cows at 3 weeks (18-24 days prepartum; -3 weeks), 2 weeks (17-11 days prepartum; -2 weeks), and 1 week (10-4 days prepar- tum; -1 weeks) before parturition; the day of calving (within 12 h post-calving; day 0); and 5 days postpartum (5 days). ALP3 activity was significantly higher in the primiparous group than in the multiparous group, whereas the activities decreased significantly in both groups after 5 days. ALP2 and ALP5 activities did not change, whereas ALP2 activity was significantly higher in the primiparous group than in the multiparous group. TRAP5b activity was significantly higher in the primiparous group than in the multiparous group and showed a transient significant increase at day 0. Ca concentration significantly decreased at day 0 in both groups; the Ca level at day 0 was significantly higher in the primiparous group than in the multiparous group. These data show that ALP3 activity in serum may indicate a change in osteoblastic bone forma- tion after calving, but further study is needed to determine the clinical application for measuring ALP isoenzymes in bovine medicine.

Go to article

Authors and Affiliations

A. Chiba
R. Onomi
K. Hatate
T. Moriyama
A. Goto
N. Yamagishi
Download PDF Download RIS Download Bibtex

Abstract

In this study, it was aimed to investigate the effect of hip dysplasia on some biochemical parameters, oxidative stress factors and hematocrit values in dogs. Hematocrit values (HTC), serum calcium (Ca), phosphorus (P) levels, serum alkaline phosphatase (ALP), creatine kinase (CK) activities and oxidative stress factors were evaluated in a total of 27 dogs with healthy hip joints (n: 11) and hip dysplasia (n: 16). There was no statistically significant difference between the two groups in terms of HCT, Ca and P values (p˃0.05). ALP and CK activities were found to be statistically significantly increased in the group with hip dysplasia compared to the control group with a healthy hip joint (p˂0.05). While malondialdehyde (MDA) level, one of the oxidative stress factors, was increased in the group with hip dysplasia, decreased glutathione (GSH) levels, catalase (CAT) and glutathione peroxidase (GSH-Px) activities were significantly decreased. There was no significant difference between the two groups in terms of superoxide dismutase (SOD) level. As a result, it was determined that oxidative stress factors differ in dogs with hip dysplasia compared to dogs with the healthy hip joint.
Go to article

Bibliography


Aebi H (1984) Catalase. Methods Enzymol 105: 121-126.

Ajadi AR, Sanni JL, Sobayo EF, Ijaopo K (2018) Evaluation of plasma trace elements and oxidant/antioxidant status in Boerboel dogs with hip dysplasia. Bulg J Vet Med 23: 1-11.

Altıner A, Atalay H, Bilal T (2018) Free radicals and the relationship with stress. Balikesir Health Sci J 7: 51-55.

Bakır B, Büyükönder H, Özer K, Belge A (1992) Studies on blood serum alkaline phosphatase enzyme activity in hip dysplasia and normal sivas kangal dogs. Proceedings of the 3rd National Veterinary Surgery Congress, pp 64-70.

Beutler E (1984) Red cell metabolism. A manual of biochemical methods. 2nd ed., Grune and Starton, New York: 160.

Birben E, Şahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. World AO J 5: 9-19.

Bostancı B, Demirkan I (2017) Determination of Prevalance of Canine Hip Dysplasia By Pennhip Method. Kocatepe Vet J 10: 269-277.

Candas A (1982) Hip dysplasias in dogs. Vet J AU 29: 235-248.

Çaptug Ö, Bilgili H (2007) Current Approaches of Canine Hip Dysplasia Part II: Clinical Diagnosis of Canine Hip Dysplasia. J Fac Vet Med Univ Erciyes 4(1): 35-42.

Dassler CL (2002) Canine hip dysplasia: Diagnosis and nonsurgical treatment. In: Slatter D, Textbook of Small Animal Surgery. 3rd ed., Saunders, Philadelphia, 2019-2029.

Denny HR, Buerworth S (2000) The Hip. In: A guide to canine and feline orthopaedic surgery. 4 ed., Blackwell Science, London: pp 455-494.

Ellman GL, Courtney KD, Andres V Jr, Feather-stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95.

Frankel S, Reitman S, Sonnen AC (1970) A textbook on laboratory procedure and their interpretation. Grand-Wohl’s clinical laboratory methods and diagnosis. Mosby Co, London, pp 403-404.

Ginja MMD, Ferreira AJA, Silvestre AM, Gonzale-Orden JM, Llorens-Pena MP (2006) Hip joint fluid and passive laxity in puppies at 7 or 8 weeks of age and its correlation with late hip laxity and canine hip dysplasia. 13th ESVOT Congress. September, 7-10, Munich, Germany, pp 232-233.

Karabaglı M, Olgun- Erdikmen D, Özer K (2014) Diagnosis and Treatment Options in Hip Dysplasia. Türkiye Klinikleri J Vet Sci 5: 54-61.

Lust G, Rendano VT, Summers BA (1985) Canine hip dysplasia: concepts and diagnosis. J Am Vet Med Assoc 187(6): 638-640.

Mukherjee S, Ghosh S, Choudhury S, Adhikary A, Manna K, Dey S, Sa G, Das T, Chattopadhyay S (2013) Pomegranate reverses metho-trexate-induced oxidative stress and apoptosis in hepatocytes by modulating Nrf2-NF-κB pathways. J Nutr Biochem 24: 2040-2050.

Or ME, Gülanber EG, Kalınbacak A, et al. (2001) The correlations of some serum parameters and hip dysplasia on Turkish Shepherd (Sivas Kangal) and German Shepherd dogs. Acta Veterinaria Eurasia 27: 469-476.

Placer ZA, Cushman L, Johnson BC (1966) Estimation of products of lipid peroxidation in biochemical systems. Anal Biochem 16: 359-364.

Prasad AS (1978) Trace elements and iron in human metabolism. John Willey and Sons, NY.

Polat E (2021) Hip dysplasia in dogs. Veterinary Medicine and a New Look at Beekeepıng. 1st ed., IKSAD Publishing House, Ankara, pp 41-74.

Sarı H, Bilgili H (2011) Evaluation of Norberg-Olsson and distraction index hip joint angles measurement using with a new computerized programme on canine hip dysplasia. Vet Hek Der Derg 82: 49-58.

Schachner ER, Lopez MJ (2015) Diagnosis, prevention, and management of canine hip dysplasia: A review. Vet Med Res Rep 6: 181-192.

Sharma U, Pal D, Prasad R (2014) Alkaline phosphatase: An overview. Indian J Clin Biochem 29: 269–278.

Sun Y, Oberley LW, Li Y (1988) A simple method for clinical assay of superoxide dismutase. Clin Chem 34: 497-500.

Szilagyi M, Sagi L (1976) Bone mineral contents and serum alkaline phosphatase activity of healthy and hip dysplasic German Sheep dogs. Acta Vet Acad Sci Hung 25: 297-301.

Teixeira AM, Borges GF (2012) Creatine kinase: structure and function. Brazi J Biomotr 6: 53-65.

Wallace LJ (1987) Canine hip dysplasia: Past and present. Semin Vet Med Surg 2: 92-106.

Zilva FJ, Pannal PR (1975) Clinical Chemistry in Diagnosis and Treatment, 2nd ed., Lloyd-Luke LTD, London.
Go to article

Authors and Affiliations

E. Polat
1
M.C. Han
1
E. Kaya
2
S. Yilmaz
2
S.D. Kayapinar
1
S. Coskun
1
A. Yildirim
1
U.K. Can
1

  1. Fırat University, Faculty of Veterinary Medicine, Department of Surgery, Elazig, Turkey
  2. Fırat University, Faculty of Veterinary Medicine, Department of Biochemistry, Elazig, Turkey

This page uses 'cookies'. Learn more